Literature DB >> 9422366

Chronic ethanol administration decreases phosphorylation of cyclic AMP response element-binding protein in granule cells of rat cerebellum.

X Yang1, K Horn, J M Baraban, G S Wand.   

Abstract

To help define the molecular basis of ethanol's actions on the nervous system, we have in previous studies demonstrated that ethanol administration triggers a robust increase in cyclic AMP-response element-binding protein (CREB) phosphorylation in the cerebellum. The purpose of the present study was to compare the effects of acute and chronic ethanol exposure on the phosphorylation of CREB in rat cerebellum and to determine which cell types in the cerebellum display this response to ethanol. An acute ethanol challenge (3.0 g/kg of body weight) induced a rapid increase in content of the phosphorylated form of CREB, peaking at 30 min and declining to basal levels within 2 h. Immunocytochemical studies revealed prominent ethanol-induced changes in phosphoCREB in the granule cell layer, with little phosphoCREB apparent in Purkinje cells. Following chronic ethanol exposure (5 weeks), induction of CREB phosphorylation by a subsequent acute ethanol challenge was markedly attenuated. The attenuation in CREB phosphorylation was associated with a significant reduction in the levels of the catalytic unit of protein kinase A and calcium/calmodulin-dependent protein kinase IV. In summary, induction of CREB phosphorylation in cerebellum is most prominent in the granule cell layer. Neuroadaptation to chronic ethanol exposure includes a reduction in nuclear protein kinase A and calcium/calmodulin-dependent protein kinase IV levels, an event associated with impaired CREB phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9422366     DOI: 10.1046/j.1471-4159.1998.70010224.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism.

Authors:  Subhash C Pandey; Huaibo Zhang; Adip Roy; Tiejun Xu
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 2.  The anxious amygdala: CREB signaling and predisposition to anxiety and alcoholism.

Authors:  Gary Wand
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

3.  Transcriptional Regulators as Targets for Alcohol Pharmacotherapies.

Authors:  Antonia M Savarese; Amy W Lasek
Journal:  Handb Exp Pharmacol       Date:  2018

Review 4.  Cyclic nucleotide phosphodiesterases: potential therapeutic targets for alcohol use disorder.

Authors:  Rui-Ting Wen; Fang-Fang Zhang; Han-Ting Zhang
Journal:  Psychopharmacology (Berl)       Date:  2018-04-16       Impact factor: 4.530

Review 5.  Signaling pathways mediating alcohol effects.

Authors:  Dorit Ron; Robert O Messing
Journal:  Curr Top Behav Neurosci       Date:  2013

Review 6.  Fetal alcohol spectrum disorders and abnormal neuronal plasticity.

Authors:  Alexandre E Medina
Journal:  Neuroscientist       Date:  2011-03-07       Impact factor: 7.519

Review 7.  Neuroscience of alcoholism: molecular and cellular mechanisms.

Authors:  Sachin Moonat; Bela G Starkman; Amul Sakharkar; Subhash C Pandey
Journal:  Cell Mol Life Sci       Date:  2009-09-10       Impact factor: 9.261

Review 8.  GSK3beta in ethanol neurotoxicity.

Authors:  Jia Luo
Journal:  Mol Neurobiol       Date:  2009-06-09       Impact factor: 5.590

9.  Adenosine transporter ENT1 regulates the acquisition of goal-directed behavior and ethanol drinking through A2A receptor in the dorsomedial striatum.

Authors:  Hyung Wook Nam; David J Hinton; Na Young Kang; Taehyun Kim; Moonnoh R Lee; Alfredo Oliveros; Chelsea Adams; Christina L Ruby; Doo-Sup Choi
Journal:  J Neurosci       Date:  2013-03-06       Impact factor: 6.167

10.  Phosphodiesterase inhibition increases CREB phosphorylation and restores orientation selectivity in a model of fetal alcohol spectrum disorders.

Authors:  Thomas E Krahe; Weili Wang; Alexandre E Medina
Journal:  PLoS One       Date:  2009-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.